Chemotherapy-Induced Nausea and Vomiting Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chemotherapy-Induced Nausea and Vomiting Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chemotherapy-Induced Nausea and Vomiting Drugs market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chemotherapy-Induced Nausea and Vomiting Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chemotherapy-Induced Nausea and Vomiting Drugs market segmented into
- Existing Drugs
- Akynzeo (Netupitant-Palonosetron FDC)
- Aloxi (Palonosetron)
- Emend (Aprepitant)
- Kytril Generic (Granisetron)
- Zofran Generic (Ondansetron)
- Pipeline Drugs
- SUSTOL (Granisetron Injection extended release)
- Rolapitant
- Serotonin Receptor Antagonists
- NK1 Receptor Antagonists
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Tesaro, Inc.
- Helsinn Group
- F. Hoffmann-La Roche Ltd.
- Heron Therapeutics, Inc.
- Dr. Reddy's Laboratories Ltd.
- Acacia Pharma
- Sun Pharmaceutical Industry Ltd.
- Otsuka Holdings Co., Ltd.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS INDUSTRY
2.1 Summary about Chemotherapy-Induced Nausea and Vomiting Drugs Industry
2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
2.2.1 Chemotherapy-Induced Nausea and Vomiting Drugs Production & Consumption Trends
2.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Demand Structure Trends
2.3 Chemotherapy-Induced Nausea and Vomiting Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Existing Drugs
4.2.2 Akynzeo (Netupitant-Palonosetron FDC)
4.2.3 Aloxi (Palonosetron)
4.2.4 Emend (Aprepitant)
4.2.5 Kytril Generic (Granisetron)
4.2.6 Zofran Generic (Ondansetron)
4.2.7 Pipeline Drugs
4.2.8 SUSTOL (Granisetron Injection extended release)
4.2.9 Rolapitant
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Serotonin Receptor Antagonists
4.3.2 NK1 Receptor Antagonists
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Existing Drugs
5.2.2 Akynzeo (Netupitant-Palonosetron FDC)
5.2.3 Aloxi (Palonosetron)
5.2.4 Emend (Aprepitant)
5.2.5 Kytril Generic (Granisetron)
5.2.6 Zofran Generic (Ondansetron)
5.2.7 Pipeline Drugs
5.2.8 SUSTOL (Granisetron Injection extended release)
5.2.9 Rolapitant
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Serotonin Receptor Antagonists
5.3.2 NK1 Receptor Antagonists
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Existing Drugs
6.2.2 Akynzeo (Netupitant-Palonosetron FDC)
6.2.3 Aloxi (Palonosetron)
6.2.4 Emend (Aprepitant)
6.2.5 Kytril Generic (Granisetron)
6.2.6 Zofran Generic (Ondansetron)
6.2.7 Pipeline Drugs
6.2.8 SUSTOL (Granisetron Injection extended release)
6.2.9 Rolapitant
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Serotonin Receptor Antagonists
6.3.2 NK1 Receptor Antagonists
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Existing Drugs
7.2.2 Akynzeo (Netupitant-Palonosetron FDC)
7.2.3 Aloxi (Palonosetron)
7.2.4 Emend (Aprepitant)
7.2.5 Kytril Generic (Granisetron)
7.2.6 Zofran Generic (Ondansetron)
7.2.7 Pipeline Drugs
7.2.8 SUSTOL (Granisetron Injection extended release)
7.2.9 Rolapitant
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Serotonin Receptor Antagonists
7.3.2 NK1 Receptor Antagonists
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Existing Drugs
8.2.2 Akynzeo (Netupitant-Palonosetron FDC)
8.2.3 Aloxi (Palonosetron)
8.2.4 Emend (Aprepitant)
8.2.5 Kytril Generic (Granisetron)
8.2.6 Zofran Generic (Ondansetron)
8.2.7 Pipeline Drugs
8.2.8 SUSTOL (Granisetron Injection extended release)
8.2.9 Rolapitant
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Serotonin Receptor Antagonists
8.3.2 NK1 Receptor Antagonists
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Existing Drugs
9.2.2 Akynzeo (Netupitant-Palonosetron FDC)
9.2.3 Aloxi (Palonosetron)
9.2.4 Emend (Aprepitant)
9.2.5 Kytril Generic (Granisetron)
9.2.6 Zofran Generic (Ondansetron)
9.2.7 Pipeline Drugs
9.2.8 SUSTOL (Granisetron Injection extended release)
9.2.9 Rolapitant
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Serotonin Receptor Antagonists
9.3.2 NK1 Receptor Antagonists
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck & Co., Inc.
10.1.2 GlaxoSmithKline plc
10.1.3 Tesaro, Inc.
10.1.4 Helsinn Group
10.1.5 F. Hoffmann-La Roche Ltd.
10.1.6 Heron Therapeutics, Inc.
10.1.7 Dr. Reddy's Laboratories Ltd.
10.1.8 Acacia Pharma
10.1.9 Sun Pharmaceutical Industry Ltd.
10.1.10 Otsuka Holdings Co., Ltd.
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Merck & Co., Inc.
10.2.2 GlaxoSmithKline plc
10.2.3 Tesaro, Inc.
10.2.4 Helsinn Group
10.2.5 F. Hoffmann-La Roche Ltd.
10.2.6 Heron Therapeutics, Inc.
10.2.7 Dr. Reddy's Laboratories Ltd.
10.2.8 Acacia Pharma
10.2.9 Sun Pharmaceutical Industry Ltd.
10.2.10 Otsuka Holdings Co., Ltd.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS INDUSTRY
2.1 Summary about Chemotherapy-Induced Nausea and Vomiting Drugs Industry
2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
2.2.1 Chemotherapy-Induced Nausea and Vomiting Drugs Production & Consumption Trends
2.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Demand Structure Trends
2.3 Chemotherapy-Induced Nausea and Vomiting Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Existing Drugs
4.2.2 Akynzeo (Netupitant-Palonosetron FDC)
4.2.3 Aloxi (Palonosetron)
4.2.4 Emend (Aprepitant)
4.2.5 Kytril Generic (Granisetron)
4.2.6 Zofran Generic (Ondansetron)
4.2.7 Pipeline Drugs
4.2.8 SUSTOL (Granisetron Injection extended release)
4.2.9 Rolapitant
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Serotonin Receptor Antagonists
4.3.2 NK1 Receptor Antagonists
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Existing Drugs
5.2.2 Akynzeo (Netupitant-Palonosetron FDC)
5.2.3 Aloxi (Palonosetron)
5.2.4 Emend (Aprepitant)
5.2.5 Kytril Generic (Granisetron)
5.2.6 Zofran Generic (Ondansetron)
5.2.7 Pipeline Drugs
5.2.8 SUSTOL (Granisetron Injection extended release)
5.2.9 Rolapitant
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Serotonin Receptor Antagonists
5.3.2 NK1 Receptor Antagonists
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Existing Drugs
6.2.2 Akynzeo (Netupitant-Palonosetron FDC)
6.2.3 Aloxi (Palonosetron)
6.2.4 Emend (Aprepitant)
6.2.5 Kytril Generic (Granisetron)
6.2.6 Zofran Generic (Ondansetron)
6.2.7 Pipeline Drugs
6.2.8 SUSTOL (Granisetron Injection extended release)
6.2.9 Rolapitant
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Serotonin Receptor Antagonists
6.3.2 NK1 Receptor Antagonists
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Existing Drugs
7.2.2 Akynzeo (Netupitant-Palonosetron FDC)
7.2.3 Aloxi (Palonosetron)
7.2.4 Emend (Aprepitant)
7.2.5 Kytril Generic (Granisetron)
7.2.6 Zofran Generic (Ondansetron)
7.2.7 Pipeline Drugs
7.2.8 SUSTOL (Granisetron Injection extended release)
7.2.9 Rolapitant
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Serotonin Receptor Antagonists
7.3.2 NK1 Receptor Antagonists
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Existing Drugs
8.2.2 Akynzeo (Netupitant-Palonosetron FDC)
8.2.3 Aloxi (Palonosetron)
8.2.4 Emend (Aprepitant)
8.2.5 Kytril Generic (Granisetron)
8.2.6 Zofran Generic (Ondansetron)
8.2.7 Pipeline Drugs
8.2.8 SUSTOL (Granisetron Injection extended release)
8.2.9 Rolapitant
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Serotonin Receptor Antagonists
8.3.2 NK1 Receptor Antagonists
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Existing Drugs
9.2.2 Akynzeo (Netupitant-Palonosetron FDC)
9.2.3 Aloxi (Palonosetron)
9.2.4 Emend (Aprepitant)
9.2.5 Kytril Generic (Granisetron)
9.2.6 Zofran Generic (Ondansetron)
9.2.7 Pipeline Drugs
9.2.8 SUSTOL (Granisetron Injection extended release)
9.2.9 Rolapitant
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Serotonin Receptor Antagonists
9.3.2 NK1 Receptor Antagonists
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck & Co., Inc.
10.1.2 GlaxoSmithKline plc
10.1.3 Tesaro, Inc.
10.1.4 Helsinn Group
10.1.5 F. Hoffmann-La Roche Ltd.
10.1.6 Heron Therapeutics, Inc.
10.1.7 Dr. Reddy's Laboratories Ltd.
10.1.8 Acacia Pharma
10.1.9 Sun Pharmaceutical Industry Ltd.
10.1.10 Otsuka Holdings Co., Ltd.
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Merck & Co., Inc.
10.2.2 GlaxoSmithKline plc
10.2.3 Tesaro, Inc.
10.2.4 Helsinn Group
10.2.5 F. Hoffmann-La Roche Ltd.
10.2.6 Heron Therapeutics, Inc.
10.2.7 Dr. Reddy's Laboratories Ltd.
10.2.8 Acacia Pharma
10.2.9 Sun Pharmaceutical Industry Ltd.
10.2.10 Otsuka Holdings Co., Ltd.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Overview
Table Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Market Share List
Table Chemotherapy-Induced Nausea and Vomiting Drugs Product Type of Major Players
Table Brief Introduction of Merck & Co., Inc.
Table Brief Introduction of GlaxoSmithKline plc
Table Brief Introduction of Tesaro, Inc.
Table Brief Introduction of Helsinn Group
Table Brief Introduction of F. Hoffmann-La Roche Ltd.
Table Brief Introduction of Heron Therapeutics, Inc.
Table Brief Introduction of Dr. Reddy's Laboratories Ltd.
Table Brief Introduction of Acacia Pharma
Table Brief Introduction of Sun Pharmaceutical Industry Ltd.
Table Brief Introduction of Otsuka Holdings Co., Ltd.
Table Products & Services of Merck & Co., Inc.
Table Products & Services of GlaxoSmithKline plc
Table Products & Services of Tesaro, Inc.
Table Products & Services of Helsinn Group
Table Products & Services of F. Hoffmann-La Roche Ltd.
Table Products & Services of Heron Therapeutics, Inc.
Table Products & Services of Dr. Reddy's Laboratories Ltd.
Table Products & Services of Acacia Pharma
Table Products & Services of Sun Pharmaceutical Industry Ltd.
Table Products & Services of Otsuka Holdings Co., Ltd.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Table Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Overview
Table Chemotherapy-Induced Nausea and Vomiting Drugs Product Type Market Share List
Table Chemotherapy-Induced Nausea and Vomiting Drugs Product Type of Major Players
Table Brief Introduction of Merck & Co., Inc.
Table Brief Introduction of GlaxoSmithKline plc
Table Brief Introduction of Tesaro, Inc.
Table Brief Introduction of Helsinn Group
Table Brief Introduction of F. Hoffmann-La Roche Ltd.
Table Brief Introduction of Heron Therapeutics, Inc.
Table Brief Introduction of Dr. Reddy's Laboratories Ltd.
Table Brief Introduction of Acacia Pharma
Table Brief Introduction of Sun Pharmaceutical Industry Ltd.
Table Brief Introduction of Otsuka Holdings Co., Ltd.
Table Products & Services of Merck & Co., Inc.
Table Products & Services of GlaxoSmithKline plc
Table Products & Services of Tesaro, Inc.
Table Products & Services of Helsinn Group
Table Products & Services of F. Hoffmann-La Roche Ltd.
Table Products & Services of Heron Therapeutics, Inc.
Table Products & Services of Dr. Reddy's Laboratories Ltd.
Table Products & Services of Acacia Pharma
Table Products & Services of Sun Pharmaceutical Industry Ltd.
Table Products & Services of Otsuka Holdings Co., Ltd.
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Merck & Co., Inc. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of GlaxoSmithKline plc 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Tesaro, Inc. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Helsinn Group 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of F. Hoffmann-La Roche Ltd. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Heron Therapeutics, Inc. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Dr. Reddy's Laboratories Ltd. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Acacia Pharma 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Sun Pharmaceutical Industry Ltd. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Otsuka Holdings Co., Ltd. 2017-2020e
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Existing Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Akynzeo (Netupitant-Palonosetron FDC) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Aloxi (Palonosetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emend (Aprepitant) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Kytril Generic (Granisetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Zofran Generic (Ondansetron) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pipeline Drugs Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure SUSTOL (Granisetron Injection extended release) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rolapitant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Serotonin Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NK1 Receptor Antagonists Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Merck & Co., Inc. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of GlaxoSmithKline plc 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Tesaro, Inc. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Helsinn Group 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of F. Hoffmann-La Roche Ltd. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Heron Therapeutics, Inc. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Dr. Reddy's Laboratories Ltd. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Acacia Pharma 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Sun Pharmaceutical Industry Ltd. 2017-2020e
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue (Million USD) of Otsuka Holdings Co., Ltd. 2017-2020e
